EGFR and neoplasm: Also, after the initial course of treatment with EGFR inhibitors, repetitive imaging with such a selective radiotracer could be used for monitoring the development of tumor lesions with acquired mutations (i.e., T790 M) conferring resistance to EGFR inhibitors.